Prognostic Index in Malignant Melanoma

Archives of Dermatology

Volumn 114, Issue 6, 1978, Pages 871-873

  Schmoeckel, Christian ^a   Braun Falco, Otto ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER IMMUNOTHERAPY; HISTOLOGY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MELANOMA; METASTASIS; PROGNOSIS; THERAPY;

FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMAN; MALE; MELANOMA; MITOSIS; NEOPLASM METASTASIS; PROGNOSIS; SKIN NEOPLASMS;

EID: 0018232991     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1978.01640180005001     Document Type: Article

References (20)

1. 1. Tonak J, Hermanek P, Hornstein OP, et al: Therapie des malignen Melanoms der klinischen Stadien I und II. Dtsch Med Wochenschr 101:435-440, 1976.
2. 2. Eilber FR, Morton DL, Holmes EC, et al: Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N Engl J Med 294:237-240, 1976.
3. 3. Gutterman JU, Mavlight G, Gottlieb JA, et al: Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and Bacillus Calmette-Guerin. N Engl J Med 291:592-597, 1974.
4. 4. Breslow A: Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 182:572-575, 1975.
5. 5. Wanebo HJ, Woodruff J, Fortner JG: Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage). Cancer 35:666-676, 1975.
6. 6. Weidner F, Hornstein OP, Hermanek P, et al: Early metastases in regional lymph nodes and prognosis of malignant melanoma: Histological and clinical examinations in 104 lymphadenectomized patients. Arch Derm Res 256:167-177, 1976.
7. 7. Cochran AJ: Malignant melanoma: A review of ten years' experience in Glasgow, Scotland. Cancer 23:1190-1199, 1969.
8. 8. Huvos AG, Shah JP, Mike V: Prognostic factors in cutaneous malignant melanoma: A comparative study of long term and short term survivors. Hum Pathol 5:347-357, 1974.
9. 9. Clark WH Jr, From L, Bernardino EA, et al: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-726, 1969.
10. 10. Gartmann H, Tritsch H: Bedeutung feingeweblicher Befunde für die Prognose des malignen Melanoms. Dtsch Med Wochenschr 97:857-859, 1972.
11. 11. Kokoschka EM, Niebauer G: Zur histologischen Prognosestellung beim primären Melanom. Wien Klin Wochenschr 88:685-689, 1976.
12. 12. Klostermann GF, Heite HJ: Das Tiefenwachstum des Melanoms in Relation zur Prognose. Arch Derm Res 244:214-217, 1972.
13. 13. Cochran AJ: Histology and prognosis in malignant melanoma. J Pathol 97:459-468, 1969.
14. 14. Williams WJ, Davies K, Jones WM, et al: Malignant melanoma of the skin: Prognostic value of histology in 89 cases. Br J Cancer 22:452-460, 1968.
15. 15. Jourdain JC: Edute de critères cliniques et histologiques du prognostic des mélanomes malins primaires. Ann Dermatol Syphiligr (Paris) 101:171-178, 1974.
16. 16. Little JH: Histology and prognosis in cutaneous malignant melanomas, in McCarthy WH (ed): Melanoma and Skin Cancer. Sydney, Australia VCN Blight, Government Printer, 1972, pp 107-119.
17. 17. McGovern VJ: Melanoma: Growth patterns, multiplicity and regression, in McCarthy WH (ed): Melanoma and Skin Cancer. Sydney, Australia, VCN Blight, Government Printer, 1972, pp 95-106.
18. 18. Christophers E, Braun-Falco O: Melanomalignom: Feingewebliche Untersuchungen und Prognose. Arch Derm Res 244:217-220, 1972.
19. 19. Cochran AJ: Method of assessing prognosis in patients with malignant melanoma. Lancet 2:1062-1064, 1968.
20. 20. Shah JP, Goldsmith HS: Prognosis of malignant melanomas in relation to clinical presentation. Am J Surg 123:286-288, 1972.